MW073

MW073 is a serotonin 5-HT 2B receptor antagonist which is used in scientific research.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

MW073 is a serotonin 5-HT 2B receptor antagonist which is used in scientific research. It is a highly selective antagonist of the serotonin 5-HT 2B receptor. The drug is orally active in animals and is said to have a favorable drug-like profile.

It produces antiaggressive effects without causing sedation or altering locomotor activity or anxiety in an animal model of Alzheimer's disease. Similarly, it produces neuroprotective, neurorestorative, and pro-cognitive-like effects in such models. MW073 was first described in the scientific literature by 2024.

There is interest in MW073 for the potential treatment of Alzheimer's disease and other conditions.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1372174635 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.